Table 2.
Association results for the eight SNPs included in the analysis
| SNP ID | MAF cases | MAF controls | p-value | Corrected p-value | OR (95% CI) |
|---|---|---|---|---|---|
| rs2651899 |
0.4519 |
0.4014 |
0.0019 |
0.0150 |
1.20 (1.07-1.35) |
| rs2274316 |
0.3598 |
0.3554 |
0.6143 |
1 |
0.97 (0.85-1.11) |
| rs1003540 |
0.1796 |
0.2069 |
0.0692 |
0.5538 |
0.81 (0.64-1.02) |
| rs4075749 |
0.3302 |
0.315 |
0.3961 |
1 |
1.06 (0.93-1.21) |
| rs9349379 |
0.4339 |
0.4389 |
0.4957 |
1 |
0.96 (0.85-1.08) |
| rs1835740 |
0.2109 |
0.1992 |
0.0075 |
0.0600 |
1.28 (1.07-1.54) |
| rs6478241 |
0.3758 |
0.361 |
0.6192 |
1 |
1.03 (0.91-1.17) |
| rs11172113 | 0.3865 | 0.4145 | 0.1569 | 1 | 0.92 (0.82-1.03) |
The disease-association test was performed using logistic regression analysis with gender as cofactor. SNP = Single Nucleotide Polymorphism; MAF = minor allele frequency; corrected p-value was calculated using the Bonferroni correction method; OR = odds ratio; 95% CI = 95% confidence interval. The significant p values are shown in bold (p < 0.05).